ABT vs. ABBV
Compare and contrast key facts about Abbott Laboratories (ABT) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or ABBV.
Correlation
The correlation between ABT and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABT vs. ABBV - Performance Comparison
Key characteristics
ABT:
1.00
ABBV:
0.70
ABT:
1.58
ABBV:
1.03
ABT:
1.19
ABBV:
1.16
ABT:
0.75
ABBV:
0.91
ABT:
2.36
ABBV:
2.11
ABT:
8.14%
ABBV:
8.21%
ABT:
19.13%
ABBV:
24.76%
ABT:
-45.66%
ABBV:
-45.09%
ABT:
0.00%
ABBV:
-0.54%
Fundamentals
ABT:
$229.17B
ABBV:
$348.39B
ABT:
$7.64
ABBV:
$2.39
ABT:
17.29
ABBV:
82.57
ABT:
2.34
ABBV:
2.63
ABT:
$30.98B
ABBV:
$56.33B
ABT:
$17.29B
ABBV:
$41.47B
ABT:
$7.89B
ABBV:
$18.15B
Returns By Period
In the year-to-date period, ABT achieves a 18.35% return, which is significantly higher than ABBV's 14.11% return. Over the past 10 years, ABT has underperformed ABBV with an annualized return of 13.07%, while ABBV has yielded a comparatively higher 17.57% annualized return.
ABT
18.35%
14.03%
19.99%
15.29%
10.75%
13.07%
ABBV
14.11%
16.38%
4.09%
18.88%
21.23%
17.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABT vs. ABBV — Risk-Adjusted Performance Rank
ABT
ABBV
ABT vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABT vs. ABBV - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 1.68%, less than ABBV's 3.13% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 1.68% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
ABBV AbbVie Inc. | 3.13% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ABT vs. ABBV - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, roughly equal to the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ABT and ABBV. For additional features, visit the drawdowns tool.
Volatility
ABT vs. ABBV - Volatility Comparison
Abbott Laboratories (ABT) and AbbVie Inc. (ABBV) have volatilities of 7.50% and 7.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABT vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities